PetMed Express (NASDAQ:PETS) Stock Passes Above 200-Day Moving Average – Time to Sell?

PetMed Express, Inc. (NASDAQ:PETS) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $4.05 and traded as high as $5.80. PetMed Express shares last traded at $5.46, with a volume of 310,128 shares traded.

Analysts Set New Price Targets

Separately, StockNews.com raised PetMed Express from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th.

PetMed Express Stock Down 0.9 %

The stock has a market cap of $112.80 million, a P/E ratio of -91.00 and a beta of 0.71. The business has a 50 day moving average price of $4.65 and a two-hundred day moving average price of $4.05.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Wednesday, November 6th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.17. The company had revenue of $59.57 million for the quarter, compared to the consensus estimate of $66.02 million. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. On average, research analysts forecast that PetMed Express, Inc. will post 0.24 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Leslie C.G. Campbell bought 15,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The shares were bought at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the completion of the transaction, the director now owns 70,000 shares of the company’s stock, valued at approximately $376,600. This represents a 27.27 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.10% of the stock is owned by company insiders.

Institutional Investors Weigh In On PetMed Express

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Sei Investments Co. raised its position in PetMed Express by 8.3% during the second quarter. Sei Investments Co. now owns 44,220 shares of the company’s stock valued at $179,000 after purchasing an additional 3,400 shares during the period. Point72 DIFC Ltd purchased a new stake in PetMed Express during the second quarter valued at approximately $34,000. Marshall Wace LLP purchased a new stake in PetMed Express during the second quarter valued at approximately $46,000. SG Americas Securities LLC purchased a new stake in PetMed Express during the second quarter valued at approximately $46,000. Finally, Legacy Advisors LLC purchased a new stake in PetMed Express during the second quarter valued at approximately $96,000. 73.33% of the stock is currently owned by hedge funds and other institutional investors.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.